Management of patients with HPV-positive and negative oropharyngeal squamous cell carcinoma
Evidence & Practice Previous     Next

Management of patients with HPV-positive and negative oropharyngeal squamous cell carcinoma

Morwenna Breeze-Milligan Staff nurse, Royal Marsden NHS Foundation Trust, London, England

A review of the impact of human papillomavirus (HPV)-positive squamous cell carcinoma of the head and neck on patients and their carers. Patients with HPV-mediated malignancy of the oropharynx present with distinct risk factors and a favourable prognosis compared to patients with HPV-negative disease. Despite the distinct clinical profile of HPV-positive malignancy, clinical recommendations do not account for HPV status. Consequently, patients with HPV-positive disease are receiving highly aggressive and often life-changing anti-cancer treatment despite a favourable prognosis.

Cancer Nursing Practice. 16, 3, 28-31. doi: 10.7748/cnp.2017.e1395

Correspondence

wennabreezemilligan@gmail.com

Peer review

This article has been subject to external double-blind peer review and checked for plagiarism using automated software

Conflict of interest

None declared

Received: 20 January 2017

Accepted: 02 March 2017